• Cinven has agreed to acquire Theramex, a women's health specialty pharmaceutical company, from Carlyle and PAI Partners.
• London-based Theramex operates in more than 80 countries; its treatments have reached more than six million women worldwide.
• The investment will support expansion in existing and new markets, alongside further licensing deals to broaden treatment access.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cinven Ltd published the original content used to generate this news brief on November 03, 2026, and is solely responsible for the information contained therein.